Psoriatic Arthritis - Global Clinical Trials Review, 2025

Description

List of Tables

GlobalData's clinical trial report, "Psoriatic Arthritis - Global Clinical Trials Review, 2025" provides an overview of Psoriatic Arthritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriatic Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Product Code: GDHC7305CTIDB

List of Tables

List of Figures

Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Psoriatic Arthritis Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Psoriatic Arthritis
Dec 17, 2025: PeptiDream Announces Pre-Clinical Results of Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for Treatment of Psoriasis
Dec 03, 2025: Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 Inhibitor O3R-5671
Nov 17, 2025: New Long-Term Data Reinforces Tremfya as the Only Il-23 Inhibitor Proven to Substantially Inhibit Structural Joint Damage in Psoriatic Arthritis
Oct 28, 2025: Sitryx Presents New Preclinical Data Highlighting MTHFD2 as a Novel Metabolic Target in Autoimmune Disease at ACR Convergence 2025
Oct 27, 2025: Bristol Myers Squibb Presents Two Late-Breaking Presentations Demonstrating Sotyktu Efficacy in Psoriatic Arthritis and Systemic Lupus Erythematosus
Oct 25, 2025: BIMZELX Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
Oct 25, 2025: Novartis showcases significant immunology advancements in ACR congress with new data on secukinumab in complex autoimmune diseases
Oct 22, 2025: Innovent Biologics Unveils Multiple Clinical and Preclinical Study Data From Its Comprehensive Pipeline
Clinical Trial Profile Snapshots

Appendix

Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source

Product Code: GDHC7305CTIDB

List of Table

List of Tables

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Region, 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2025*
Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2025*
Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2025*
Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2025*
Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2025*
Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2025*
Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Phase, 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2020-2024
Psoriatic Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2025*

List of Figure

List of Figures

Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2025*
Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2025*
Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2025*
Psoriatic Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2025*
Proportion of Psoriatic Arthritis to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2025*
Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2025*
Psoriatic Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2025*
Psoriatic Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2020-2024
Psoriatic Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2025*
Psoriatic Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2025*
GlobalData Methodology

Psoriatic Arthritis - Global Clinical Trials Review, 2025

Description

Table of Contents

List of Tables

Scope

Reasons to Buy

Table of Contents

Table of Contents

List of Tables

List of Figures

Appendix

List of Table

List of Tables

List of Figure

List of Figures